ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/16 | 5,480 | 5,490 | 5,330 | 5,330 | -100 | -1.8% | 407,700 |
2020/12/15 | 5,480 | 5,510 | 5,420 | 5,430 | +40 | +0.7% | 459,000 |
2020/12/14 | 5,490 | 5,510 | 5,390 | 5,390 | -120 | -2.2% | 316,300 |
2020/12/11 | 5,430 | 5,530 | 5,420 | 5,510 | +80 | +1.5% | 384,600 |
2020/12/10 | 5,250 | 5,430 | 5,220 | 5,430 | +110 | +2.1% | 402,100 |
2020/12/09 | 5,290 | 5,340 | 5,230 | 5,320 | +110 | +2.1% | 302,600 |
2020/12/08 | 5,250 | 5,250 | 5,150 | 5,210 | -110 | -2.1% | 402,300 |
2020/12/07 | 5,420 | 5,450 | 5,270 | 5,320 | -100 | -1.8% | 389,500 |
2020/12/04 | 5,520 | 5,540 | 5,370 | 5,420 | -130 | -2.3% | 379,500 |
2020/12/03 | 5,420 | 5,620 | 5,420 | 5,550 | +110 | +2% | 506,700 |
2020/12/02 | 5,400 | 5,530 | 5,370 | 5,440 | -50 | -0.9% | 625,400 |
2020/12/01 | 5,290 | 5,520 | 5,280 | 5,490 | +170 | +3.2% | 961,400 |
2020/11/30 | 5,180 | 5,330 | 5,160 | 5,320 | +140 | +2.7% | 1,124,500 |
2020/11/27 | 5,020 | 5,180 | 5,010 | 5,180 | +160 | +3.2% | 1,452,500 |
2020/11/26 | 4,985 | 5,060 | 4,935 | 5,020 | +10 | +0.2% | 382,300 |
2020/11/25 | 4,970 | 5,090 | 4,940 | 5,010 | +160 | +3.3% | 768,800 |
2020/11/24 | 4,905 | 4,935 | 4,800 | 4,850 | +50 | +1% | 532,400 |
2020/11/20 | 4,705 | 4,800 | 4,675 | 4,800 | +5 | +0.1% | 419,500 |
2020/11/19 | 4,800 | 4,810 | 4,680 | 4,795 | -10 | -0.2% | 595,100 |
2020/11/18 | 4,775 | 4,885 | 4,760 | 4,805 | +30 | +0.6% | 484,400 |
2020/11/17 | 5,060 | 5,070 | 4,740 | 4,775 | -325 | -6.4% | 822,200 |
2020/11/16 | 5,220 | 5,240 | 5,090 | 5,100 | -80 | -1.5% | 396,200 |
2020/11/13 | 5,140 | 5,220 | 5,060 | 5,180 | +40 | +0.8% | 547,300 |
2020/11/12 | 5,140 | 5,200 | 5,100 | 5,140 | +20 | +0.4% | 381,200 |
2020/11/11 | 5,090 | 5,160 | 5,060 | 5,120 | +80 | +1.6% | 443,300 |
2020/11/10 | 5,070 | 5,140 | 5,000 | 5,040 | -40 | -0.8% | 493,100 |
2020/11/09 | 5,080 | 5,100 | 5,010 | 5,080 | +60 | +1.2% | 342,400 |
2020/11/06 | 5,100 | 5,150 | 5,000 | 5,020 | -70 | -1.4% | 525,300 |
2020/11/05 | 5,000 | 5,100 | 4,980 | 5,090 | +120 | +2.4% | 479,400 |
2020/11/04 | 4,970 | 4,995 | 4,885 | 4,970 | +60 | +1.2% | 555,200 |
2020/11/02 | 4,850 | 4,925 | 4,835 | 4,910 | +85 | +1.8% | 363,500 |
2020/10/30 | 4,875 | 4,905 | 4,820 | 4,825 | -80 | -1.6% | 394,700 |
2020/10/29 | 4,780 | 4,905 | 4,780 | 4,905 | +85 | +1.8% | 301,300 |
2020/10/28 | 4,800 | 4,855 | 4,765 | 4,820 | +20 | +0.4% | 253,400 |
2020/10/27 | 4,740 | 4,820 | 4,685 | 4,800 | +45 | +0.9% | 256,800 |
2020/10/26 | 4,840 | 4,910 | 4,755 | 4,755 | -100 | -2.1% | 395,800 |
2020/10/23 | 4,765 | 4,860 | 4,730 | 4,855 | +20 | +0.4% | 355,500 |
2020/10/22 | 4,890 | 4,890 | 4,750 | 4,835 | -70 | -1.4% | 406,300 |
2020/10/21 | 4,900 | 5,020 | 4,900 | 4,905 | +25 | +0.5% | 363,300 |
2020/10/20 | 4,910 | 4,960 | 4,875 | 4,880 | -60 | -1.2% | 367,100 |
2020/10/19 | 4,990 | 5,010 | 4,875 | 4,940 | -45 | -0.9% | 460,200 |
2020/10/16 | 5,020 | 5,090 | 4,970 | 4,985 | -85 | -1.7% | 274,500 |
2020/10/15 | 5,070 | 5,140 | 5,020 | 5,070 | -40 | -0.8% | 310,800 |
2020/10/14 | 5,070 | 5,180 | 5,060 | 5,110 | +80 | +1.6% | 516,900 |
2020/10/13 | 4,960 | 5,060 | 4,935 | 5,030 | +105 | +2.1% | 369,600 |
2020/10/12 | 4,890 | 4,955 | 4,885 | 4,925 | +35 | +0.7% | 218,400 |
2020/10/09 | 4,900 | 4,940 | 4,860 | 4,890 | +25 | +0.5% | 361,700 |
2020/10/08 | 4,880 | 4,940 | 4,835 | 4,865 | +15 | +0.3% | 329,800 |
2020/10/07 | 4,835 | 4,865 | 4,785 | 4,850 | +20 | +0.4% | 325,300 |
2020/10/06 | 4,800 | 4,925 | 4,780 | 4,830 | +55 | +1.2% | 434,200 |
1101~
1150
件表示中 / 2937件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 168,800円 | +5.0% | +1.5% | 0.00% | 14.44倍 | 3.84倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
ツムラ | 334,600円 | +3.8% | -19.9% | 4.06% | 10.87倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 352,300円 | +8.0% | -15.3% | 3.52% | 9.89倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 295,500円 | - | - | 0.00% | - | 136.87倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
サワイGHD | 183,600円 | +5.9% | +684.6% | 3.00% | 12.18倍 | 1.22倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム